A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: Regulatory effects of pro-inflammatory cytokines

Histochemistry and Cell Biology

Volumn 139, Issue 2, 2013, Pages 371-379

  Lisi, Sabrina ^a   Sisto, Margherita ^a   Lofrumento, Dario Domenico ^b   D'Amore, Massimo ^a   De Lucro, Raffaella ^a   Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

CXCR2; GRO ; Salivary gland; Sj gren's syndrome

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; GROWTH RELATED ONCOPROTEIN ALPHA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; CXCL1 PROTEIN, HUMAN; CYTOKINE; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SJOEGREN SYNDROME; GENETICS; METABOLISM; MIDDLE AGED; SJOGREN'S SYNDROME;

ADULT; AGED; CELLS, CULTURED; CHEMOKINE CXCL1; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-8B; RECOMBINANT PROTEINS; SJOGREN'S SYNDROME;

EID: 84877134779     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-1035-z     Document Type: Article

References (32)

1. Bechara C, Chai H, Lin PH, Yao Q, Chen C (2007) Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 13:RA87-RA90
2. Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P (2008) A potential role of the CXC chemokine GROα in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 28:1005-1011
3. Canavese M, Altruda F, Ruzicka T, Schauber J (2010) Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis-a possible target for novel therapies? J Dermatol Sci 58:171-176
4. Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C, Hu T, Ransohoff RM (2008) Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112:256-263
5. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621
6. Crivellato E, Ribatti D (2005) Involvement of mast cells in angiogenesis and chronic inflammation. Curr Drug Targets Inflamm Allergy 4:9-11
7. Dogan RN, Karpus WJ (2004) Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation. Front Biosci 9:1500-1505
8. Figueroa-Vega N, Anz-Cameno P, Moreno-Otero R, Sánchez-Madrid F, González-Amaro R, Marazuela M (2009) Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features. J Clin Endocrinol Metab 94:1145-1153
9. Filipovic R, Jakovcevski I, Zecevic N (2003) GRO-α and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 25:279-290
10. Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S (2003) Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. J Rheumatol 30:1524-1528
11. Glabinski AR, Tuohy VK, Ransohoff RM (1998) Expression of chemokines RANTES, MIP-1α and GRO-α correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5:166-171
12. Hsieh SC, Wu TH, Tsai CY, Li KJ, Lu MC, Wu CH, Yu CL (2008) Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus. Rheumatology (Oxford) 47:150-157
13. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD (1997) The codependence of angiogenesis and chronic inflammation. FASEB J 11:457-465
14. Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C (2010) Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum 62:1921-1932
15. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124:126-133
16. Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9:S3
17. Lisi S, Sisto M, Lofrumento DD, Cucci L, Frassanito MA, Mitolo V, D'Amore M (2010) Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of furin-TACE-amphiregulin axis. J Autoimmun 35:160-170
18. Mackay CR (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95-101
19. Min SH, Wang Y, Gonsiorek W, Anilkumar G, Kozlowski J, Lundell D, Fine JS, Grant EP (2010) Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem Biophys Res Commun 391:1080-1086
20. Reutershan J (2006) CXCR2: the receptor to hit? Drug News Perspect 19:615-623
21. Ribatti D, Crivellato E (2009) Immune cells and angiogenesis. J Cell Mol Med 13:2822-2833
22. Richmond A, Thomas HG (1986) Purification of melanoma growth stimulatory activity. J Cell Physiol 129:375-384
23. Robak E, Sysa-Jedrzejewska A, Robak T (2003) Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus. Mediators Inflamm 12:293-298
24. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M (1995) Stimulation by thyroid-stimulating hormone and grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96:1295-1302
25. Sisto M, Lisi S, Lofrumento DD, Ingravallo G, Mitolo V, D'Amore M (2010) Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands. Histochem Cell Biol 134:345-353
26. Sisto M, Lisi S, Lofrumento DD, D'Amore M, Frassanito MA, Ribatti D (2012a) Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. Genes Immun 13:411-420
27. Sisto M, Lisi S, Lofrumento DD, D'Amore M, Ribatti D (2012b) Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularization. Histochem Cell Biol 137:669-677
28. Tham E, Gielen AW, Khademi M, Martin C, Piehl F (2006) Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol 64:609-622
29. Uchida T, Nakashima M, Hirota Y, Miyazaki Y, Tsukazaki T, Shindo H (2000) Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 59:607-614
30. Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG (1997) Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15:2687-2698
31. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. European study group on classification criteria for Sjögren's syndrome. Ann Rheum Dis 61:554-558
32. Voulgarelis M, Tzioufas AG (2010) Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 6:529-537